Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2020/07/026601
CTRI/2020/07/026601
Completed
Phase 2

A prospective, interventional, single group study to evaluate safety and effectiveness of an Ayurvedic regimen as an add on treatment in hospitalized SARS-CoV2 tested positive pre-symptomatic, mild or moderate COVID-19 cases - COVID-19

Aarti Foundation Mumbai and Kutchhi Jain Foundation Mumbai0 sites61 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Sponsor
Aarti Foundation Mumbai and Kutchhi Jain Foundation Mumbai
Enrollment
61
Status
Completed
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 23, 2020
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Aarti Foundation Mumbai and Kutchhi Jain Foundation Mumbai

Eligibility Criteria

Inclusion Criteria

  • •1\. Individuals of either sex above 18
  • •2\. People who have been tested positive to be infected with SARS\-CoV2 virus and presenting with no symptoms or mild to moderate symptoms.
  • •3\. Subject who agrees for giving informed consent and provide signed and dated written IEC approved Informed Consent Form (ICF) prior to initiation of any study procedures

Exclusion Criteria

  • •1\. Subjects who are not able to or not willing to sign an IRB/IEC approved consent form.
  • •2\. COVID patients with symptoms classified as severe or critical.
  • •3\. Persons with severe primary respiratory disease or other pneumonia
  • •4\. Pregnant women
  • •5\. Persons with serious complications of diseases such as cancer, heart disease, stroke, disabilities, mental illnesses, etc., and who are considered to be excluded from the study as evaluated by the investigators
  • •6\. COVID\-19 positive cases participating as subjects in the interventional arm of other COVID\-19 clinical trials

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
An interventional study to assess the effect of spiritual therapy in the treatment of autistic childreHealth Condition 1: F01-F99- Mental, Behavioral and Neurodevelopmental disorders
CTRI/2022/06/043459Bhaktivedanta Hospital and Research Institute
Active, not recruiting
Phase 3
Efficacy and safety of Sirolimus granules twice daily administration in patients with intractuable vascular malformationsIntractable vascular malformationsVascular disordersD054079
JPRN-jRCTs031200055Mochizuki Shinji11
Active, not recruiting
Not Applicable
Aquablation Pilot Study for the treatment of Benign Prostatic Hyperplasia.
ACTRN12613000167763PROCEPT BioRobotics Corporation30
Not yet recruiting
Not Applicable
Accuracy of continuous glucose monitoring in cardiac surgeryNot Applicable
KCT0009396The Catholic University of Korea, Seoul St. Mary's Hospital42
Recruiting
Not Applicable
A single-center, prospective, observational study investigating the levels of insulin antagonist hormones on diabetic ketosis and hyperglycemic emergencies on admissiodiabetes mellitusdiabetic ketosis, diabetic ketoacidosis, hyperosmolar hyperglycemic stateD003920
JPRN-jRCT1030200267Suzuki Agena30